Dialysis Research and N-of-1 Trials: Made for Each Other?

[21] DEXTROMETHORPHAN FOR THE TREATMENT OF NEUROPATHIC PAIN - A DOUBLE-BLIND RANDOMIZED CONTROLLED CROSSOVER TRIAL WITH INTEGRAL N-OF-1 DESIGN [J]. PAIN, 1994, 59 (01) : 127 - 133

[22] Blood pressure lowering efficacy of renin inhibitors for primary hypertension: a Cochrane systematic review [J]. JOURNAL OF HUMAN HYPERTENSION, 2009, 23 (08) : 495 - 502

[23] An n-of-1 trial service in clinical practice:: Testing the effectiveness of stimulants for attention-deficit/hyperactivity disorder [J]. PEDIATRICS, 2006, 117 (06) : 2040 - 2046

[24] Anemia in chronic kidney disease: An opportunity and challenge for disease management [J]. DISEASE MANAGEMENT, 2008, 11 (01): : 47 - 48

[25] Economic Considerations in a Changing Anemia Environment [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 2008, 52 (06) : S29 - S33

[26] Ferric gluconate treatment provides cost savings in patients with high ferritin and low transferrin saturation [J]. KIDNEY INTERNATIONAL, 2008, 74 (12) : 1588 - 1595

[27] Pope JE, 2004, J RHEUMATOL, V31, P140

[28] Metabolic and Hemodynamic Advantages of an Acetate-Free Citrate Dialysate in a Uremic Case of Congenital Methylmalonic Acidemia [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 2009, 54 (04) : 764 - 769

[29] SUSPENDED JUDGMENT N-OF-1 TRIALS [J]. CONTROLLED CLINICAL TRIALS, 1993, 14 (01): : 1 - 5

[30] Senn S., 1993, CROSS OVER TRIALS CL

[21] DEXTROMETHORPHAN FOR THE TREATMENT OF NEUROPATHIC PAIN - A DOUBLE-BLIND RANDOMIZED CONTROLLED CROSSOVER TRIAL WITH INTEGRAL N-OF-1 DESIGN [J]. PAIN, 1994, 59 (01) : 127 - 133

[22] Blood pressure lowering efficacy of renin inhibitors for primary hypertension: a Cochrane systematic review [J]. JOURNAL OF HUMAN HYPERTENSION, 2009, 23 (08) : 495 - 502

[23] An n-of-1 trial service in clinical practice:: Testing the effectiveness of stimulants for attention-deficit/hyperactivity disorder [J]. PEDIATRICS, 2006, 117 (06) : 2040 - 2046

[24] Anemia in chronic kidney disease: An opportunity and challenge for disease management [J]. DISEASE MANAGEMENT, 2008, 11 (01): : 47 - 48

[25] Economic Considerations in a Changing Anemia Environment [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 2008, 52 (06) : S29 - S33

[26] Ferric gluconate treatment provides cost savings in patients with high ferritin and low transferrin saturation [J]. KIDNEY INTERNATIONAL, 2008, 74 (12) : 1588 - 1595

[27] Pope JE, 2004, J RHEUMATOL, V31, P140

[28] Metabolic and Hemodynamic Advantages of an Acetate-Free Citrate Dialysate in a Uremic Case of Congenital Methylmalonic Acidemia [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 2009, 54 (04) : 764 - 769

[29] SUSPENDED JUDGMENT N-OF-1 TRIALS [J]. CONTROLLED CLINICAL TRIALS, 1993, 14 (01): : 1 - 5

[30] Senn S., 1993, CROSS OVER TRIALS CL